The Discounted Cash Flow (DCF) valuation of Cosmo Pharmaceuticals NV (COPN.SW) is 31.77 CHF. With the latest stock price at 60.50 CHF, the upside of Cosmo Pharmaceuticals NV based on DCF is -47.5%.
| Range | Selected | |
| WACC / Discount Rate | 3.8% - 6.4% | 5.1% |
| Long-term Growth Rate | 2.5% - 3.5% | 3.0% |
| Fair Price | 18.35 - 240.20 | 31.77 |
| Upside | -69.7% - 297.0% | -47.5% |